1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Jaundice: new trials by email Literature Review of Jaundice trials Research Report on Jaundice
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis RTX001 - End-stage Liver Disease (ESLD), Cirrhosis, Liver | Phase 1 / Phase 2 | Active not recruiting | Resolution Therapeutics Limited | 30 | 2024-10-15 | 2026-10-05 |
End Stage Liver Disease (1) · Fibrosis (1) · Hepatic Encephalopathy (1) · Liver Cirrhosis (1) · Liver Diseases (1)
Brain Diseases (1) · Brain Diseases, Metabolic (1) · Central Nervous System Diseases (1) · Digestive System Diseases (1) · Hepatic Insufficiency (1) · Hyperbilirubinemia (1) · Liver Failure (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Manifestations (1)
Resolution Therapeutics Limited (1)
Spain (1) · United Kingdom (1)